Application Note: Octet® AAVX biosensors for quantitation of AAV capsids
18 November 2022

Adeno-associated virus (AAV), with low immunogenicity and toxicity, has become one of the most promising viral vectors in the field of gene therapy. A rapid and robust method for AAV capsid quantitation is essential for AAV bioprocess development and manufacturing. This tech note introduces a rapid, label-free method for direct capture and quantitation of various AAV serotypes on the Octet® Bio-Layer Interferometry (BLI) Platform using the Octet® AAVX Biosensors.